The guidance raise and strong same-facility occupancy/skilled mix trends signal accelerating organic growth. Traders should watch for continued acquisition momentum in H2 2026 and monitor the Q3 2026 earnings call for any changes to the reimbursement or regulatory environment. The stock's historical T+20 alpha has been negative on neutral reports, but this bullish catalyst with raised guidance may break that pattern.
Price Chart
Executive Summary
The Ensign Group reported Q2 2026 GAAP diluted EPS of $1.68 (up 16.7% YoY) and adjusted EPS of $1.92 (up 20.8% YoY), with total revenue of $1.44B (+17.3% YoY). The company raised its full-year 2026 EPS guidance to $7.75-$7.85 and revenue guidance to $5.87B-$5.92B, reflecting strong operational momentum driven by occupancy gains, skilled mix improvement, and disciplined acquisition growth. The beat was modest vs consensus ($1.85 EPS on $1.44B revenue), but the guidance raise and robust clinical/operating metrics support a bullish outlook.
Key Financial Metrics
Key Facts
- GAAP diluted EPS of $1.68, +16.7% YoY; adjusted EPS of $1.92, +20.8% YoY
- Total revenue $1.44B, +17.3% YoY; service revenue $1.43B, +17.3% YoY
- Same-facility occupancy 84.1% (+2.7pp YoY); skilled mix revenue +10.1% YoY
- Raised FY2026 EPS guidance to $7.75-$7.85 (midpoint +18.7% vs 2025) and revenue to $5.87B-$5.92B
- Added 20 new operations in Q2, all with real estate; portfolio now 398 facilities across 17 states
- Standard Bearer FFO $24.7M (+34.6% YoY); rental revenue $44.1M (+40.2% YoY)
- Cash and credit facility liquidity ~$854M; paid quarterly dividend of $0.065/share
Financial Impact
Revenue $1.44B (+17.3% YoY), GAAP net income $99.7M (+18.2% YoY), adjusted net income $114.3M (+22.5% YoY)
Risk Factors
- Medicaid/Medicare reimbursement rate changes or regulatory shifts
- Integration risk from rapid acquisition pace (20 new operations in Q2)
- Labor cost inflation and nursing staff shortages could pressure margins
- Occupancy at recently acquired facilities (76.6%) trails same-facility levels (84.1%)
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3333337 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 27, 2026 9w ago | 8-K | $178.07 $179.37 | ▲ +0.73% | ▼ −2.57% | $172.60 (−3.07%) |
Jul 27, 2026 9w ago | Press Release | $178.07 $179.37 | ▲ +0.73% | ▼ −2.57% | $172.60 (−3.07%) |
Jul 2, 2026 13w ago | Press Release | $168.22 $178.83 | ▲ +6.31% | ▲ +6.72% | $172.60 (+2.60%) |
Jun 19, 2026 15w ago | Press Release | $156.78 $171.28 | ▲ +9.25% | ▲ +9.40% | $172.60 (+10.09%) |
Jun 12, 2026 16w ago | Institutional Cluster | $149.37 $168.59 | ▲ +12.87% | ▲ +11.09% | $172.60 (+15.55%) |
Jun 2, 2026 17w ago | Press Release | $165.70 $164.82 | ▼ −0.53% | ▲ +1.03% | $172.60 (+4.16%) |
Jun 2, 2026 17w ago | Press Release | $165.70 $164.82 | ▼ −0.53% | ▲ +1.03% | $172.60 (+4.16%) |
Apr 28, 2026 22w ago | Press Release | $188.30 $171.97 | ▼ −8.67% | ▼ −14.13% | $172.60 (−8.34%) |
Apr 20, 2026 23w ago | 144 | $197.55 $176.66 | ▼ −10.57% | ▼ −14.78% | $172.60 (−12.63%) |
Mar 20, 2026 28w ago | Press Release | $200.02 $197.55 | ▼ −1.23% | ▼ −10.55% | $172.60 (−13.71%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access